Skip to main content

Is a personalized pharmacotherapeutic approach closed for acute coronary syndrome?

Publication ,  Journal Article
Tantry, US; Rout, A; Bliden, KP; Gurbel, PA
Published in: Expert Opin Pharmacother
April 2021

Duke Scholars

Published In

Expert Opin Pharmacother

DOI

EISSN

1744-7666

Publication Date

April 2021

Volume

22

Issue

5

Start / End Page

527 / 529

Location

England

Related Subject Headings

  • Platelet Aggregation Inhibitors
  • Pharmacology & Pharmacy
  • Percutaneous Coronary Intervention
  • Humans
  • Acute Coronary Syndrome
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tantry, U. S., Rout, A., Bliden, K. P., & Gurbel, P. A. (2021). Is a personalized pharmacotherapeutic approach closed for acute coronary syndrome? Expert Opin Pharmacother, 22(5), 527–529. https://doi.org/10.1080/14656566.2021.1877659
Tantry, Udaya S., Amit Rout, Kevin P. Bliden, and Paul A. Gurbel. “Is a personalized pharmacotherapeutic approach closed for acute coronary syndrome?Expert Opin Pharmacother 22, no. 5 (April 2021): 527–29. https://doi.org/10.1080/14656566.2021.1877659.
Tantry US, Rout A, Bliden KP, Gurbel PA. Is a personalized pharmacotherapeutic approach closed for acute coronary syndrome? Expert Opin Pharmacother. 2021 Apr;22(5):527–9.
Tantry, Udaya S., et al. “Is a personalized pharmacotherapeutic approach closed for acute coronary syndrome?Expert Opin Pharmacother, vol. 22, no. 5, Apr. 2021, pp. 527–29. Pubmed, doi:10.1080/14656566.2021.1877659.
Tantry US, Rout A, Bliden KP, Gurbel PA. Is a personalized pharmacotherapeutic approach closed for acute coronary syndrome? Expert Opin Pharmacother. 2021 Apr;22(5):527–529.

Published In

Expert Opin Pharmacother

DOI

EISSN

1744-7666

Publication Date

April 2021

Volume

22

Issue

5

Start / End Page

527 / 529

Location

England

Related Subject Headings

  • Platelet Aggregation Inhibitors
  • Pharmacology & Pharmacy
  • Percutaneous Coronary Intervention
  • Humans
  • Acute Coronary Syndrome
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences